Alternative Wnt-signaling axis leads to a break of oncogene-induced senescence

Viola Kluge1, Melanie Kappelmann-Fenzl1,2, Stefan Fischer2

  • 1Institute of Biochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Cell Death & Disease
|February 22, 2024
PubMed

Insights

Researchers discovered a new signaling pathway involving YAP and Wnt molecules that allows melanoma cells to bypass oncogene-induced senescence (OIS). This finding reveals a key mechanism driving melanoma development and offers potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Oncogene-induced senescence (OIS) is a crucial tumor suppressor mechanism.
  • BRAFV600E mutation in melanocytes can lead to melanoma by overcoming OIS, but the underlying mechanisms remain unclear.
  • YAP (Yes-associated protein) activity is induced in OIS and melanoma cells, suggesting its role may involve altered interactions rather than activation itself.

Purpose of the Study:

  • To investigate the molecular mechanisms by which BRAFV600E-mutated melanocytes overcome OIS.
  • To explore the role of YAP and Wnt signaling in melanoma progression and OIS evasion.
  • To identify novel interaction partners and signaling pathways involved in melanoma development.

Main Methods:

  • Utilized an established OIS model of primary melanocytes transduced with BRAFV600E.
  • Investigated YAP activity and Wnt signaling activation (using AMBMP).
  • Performed gene depletion studies for Wnt6, Wnt10b, and β-catenin in melanoma cells.
  • Analyzed YAP-β-catenin interactions on DNA and downstream gene expression changes.

Main Results:

  • YAP activity was induced in OIS and melanoma cells.
  • Wnt signaling activation disrupted OIS in BRAFV600E-transduced melanocytes.
  • Depletion of Wnt6, Wnt10b, or β-catenin induced senescence in melanoma cells.
  • Discovered β-catenin as a DNA-binding interaction partner of YAP in melanoma cells.
  • The β-catenin-YAP interaction shifted gene expression from senescence-stabilizing to tumor-supportive genes via LEF1/TEAD coactivation.
  • Target genes involved in rRNA processing, regulated by LEF1/TEAD, correlate with poor melanoma prognosis.

Conclusions:

  • An alternative YAP-Wnt signaling axis is essential for disrupting OIS in melanocytes.
  • The interaction between YAP and β-catenin alters gene expression, promoting tumor progression.
  • This pathway represents a novel molecular mechanism underlying melanoma development and suggests potential therapeutic targets.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.1K